The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial
Abstract
Objective— To test the hypothesis whether determination of high-density lipoprotein (HDL) subpopulations provides more power to predict recurrent cardiovascular disease (CVD) events (nonfatal myocardial infarction, coronary heart disease death, and stroke) than traditional risk factors in the Veterans Affairs HDL Intervention Trial (VA-HIT). Methods and Results— Apolipoprotein A-I (apoA-I)–containing HDL subpopulations were quantitatively determined by nondenaturing 2D gel electrophoresis. Hazard ratios of recurrent CVD events were calculated by comparing VA-HIT subjects with (n=398) and without (n=1097) such events. Subjects with new CVD events had significantly lower HDL-C, apoA-I, and large cholesterol-rich HDL particle (α-1, α-2, pre–α-1, and pre–α-2) levels, significantly higher triglyceride, and small poorly lipidated HDL particle (pre–β-1 and α-3) levels than subjects without such events. Multivariate analyses indicated that α-1 and α-2 particle levels were significant negative risk factors, whereas α-3 level was a significant positive risk factor for new CVD events. Pre–β-1 level was a significant risk factor for new CVD events only in univariate analysis. A forward selection model indicated that α-1 was the most significant risk factor for recurrent CVD events among HDL particles. Conclusions— An altered HDL subpopulation profile marked with low α-1 and α-2 levels and a high α-3 level in coronary heart disease patients indicated an elevated risk for new CVD events. Moreover, α-1 and α-2 levels were superior to HDL-C levels in risk assessment in patients with low HDL-C in VA-HIT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prebeta-1 HDL levels positively associate with increased risk of new CVD events,34 with ischemic heart disease,35 and with both coronary artery disease and myocardial infarction.36”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [34]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Self-citationDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
Molecular physiology of reverse cholesterol transport.
Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_25 · Cited by 832
Assmann, G., Schulte, H., von Eckardstein, A., & Huang, Y. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05852-2 · Cited by 700
Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
Castro, G. R., & Fielding, C. J. (1988) · Biochemistry · doi:10.1021/bi00401a005 · Cited by 641
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
Goldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 390
Apolipoprotein A-I containing lipoproteins in coronary artery disease
Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J. L., Bertrand, M. E., Koren, E., & Fruchart, J. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90091-8 · Cited by 326
Asztalos, B. F., Cupples, L. A., Demissie, S., Horvath, K. V., Cox, C. E., Batista, M. C., & Schaefer, E. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000146325.93749.a8 · Cited by 298
Self-citationAn overview of reverse cholesterol transport.
Tall, A. R. (1998) · PubMed · Cited by 246
Asztalos, B. F., Sloop, C. H., Wong, L., & Roheim, P. S. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90253-6 · Cited by 235
Self-citationParra, H. J., Arveiler, D., Evans, A. E., Cambou, J., Amouyel, P., Bingham, A., McMaster, D., Schaffer, P., DOUSTE‐BLAZY, P., & Luc, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.701 · Cited by 232
Buring, J. E., O'Connor, G. T., Goldhaber, S. Z., ROSNER, B. A., Herbert, P. N., Blum, C. B., Breslow, J. L., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.22 · Cited by 224
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
Asztalos, B. F., Roheim, P. S., Milani, R. V., LeFevre, M. L., McNamara, J. R., Horvath, K. V., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2670 · Cited by 193
Self-citationPhysiological role and clinical relevance of high-density lipoprotein subclasses
von Eckardstein, A., Huang, Y., & Assmann, G. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199412000-00003 · Cited by 152
Nanjee, M. N., Cooke, C. J., Garvin, R. A., Semeria, F. J., Lewis, G. F., Olszewski, W. L., & Miller, N. E. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32212-4 · Cited by 144
Change in α 1 HDL Concentration Predicts Progression in Coronary Artery Stenosis
Asztalos, B. F., Batista, M. C., Horvath, K. V., Cox, C. E., Dallal, G. E., Morse, J. S., Brown, G. B., & Schaefer, E. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000066133.32063.bb · Cited by 137
Self-citationFruchart, J. C., & Ailhaud, G. P. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.6.793 · Cited by 121
Miida, T., Kawano, M., Fielding, C. J., & Fielding, P. E. (1992) · Biochemistry · doi:10.1021/bi00160a022 · Cited by 109
Asztalos, B. F., Horvath, K. V., McNamara, J. R., Roheim, P. S., Rubinstein, J. J., & Schaefer, E. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00149-1 · Cited by 109
Self-citationBloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99
Self-citationApolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
Asztalos, B. F., Horvath, K. V., Kajinami, K., Nartsupha, C., Cox, C. E., Batista, M. C., Schaefer, E. J., Inazu, A., & Mabuchi, H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300198-jlr200 · Cited by 98
Self-citationSweetnam, P. M., Bolton, C. H., Yarnell, J. W., Bainton, D., Baker, I. A., Elwood, P. C., & Miller, N. E. (1994) · Circulation · doi:10.1161/01.cir.90.2.769 · Cited by 98
Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
Asztalos, B. F., Brousseau, M. E., McNamara, J. R., Horvath, K. V., Roheim, P. S., & Schaefer, E. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00643-2 · Cited by 94
Self-citationDifferent reactivities of high density lipoprotein2 subfractions with hepatic lipase.
Mowri, H., Patsch, W., Smith, L., Gotto, A. M., & Patsch, J. R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40541-3 · Cited by 89
Pre beta 1-high-density lipoprotein increases in coronary artery disease
Miida, T., Nakamura, Y., Inano, K., Matsuto, T., Yamaguchi, T., Tsuda, T., & Okada, M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.12.1992 · Cited by 78
Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients
Asztalos, B. F., Horvath, K. V., McNamara, J. R., Roheim, P. S., Rubinstein, J. J., & Schaefer, E. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200037-jlr200 · Cited by 65
Self-citationSR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome
Yancey, P. G., Asztalos, B. F., Stettler, N., Piccoli, D. A., Williams, D. L., Connelly, M. A., & Rothblat, G. H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400133-jlr200 · Cited by 37
Self-citationConcentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Montali, A., Vega, G. L., & Grundy, S. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.511 · Cited by 37
Remodeling of HDL remnants generated by scavenger receptor class B type I
Webb, N. R., de Beer, M. C., Asztalos, B. F., Whitaker, N. L., van der Westhuyzen, D. R., & de Beer, F. C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400026-jlr200 · Cited by 26
Self-citationFielding, C. J., & Fielding, P. E. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)63017-1 · Cited by 14
Cited by
Sorted by citations
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 754
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 663
WALLDIUS, G., & JUNGNER, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01643.x · Cited by 583
Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.155333 · Cited by 523
Self-citation
Metadata
- Authors
- Asztalos, B. F., Collins, D., Cupples, L. A., Demissie, S., Horvath, K. V., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J.
- Affiliations
- Boston University (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2005-10
- Volume
- 25
- Issue
- 10
- Pages
- 2185-2191
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2160230170
- Cited by
- 268
- References
- 35
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 12 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 14 · 2013: 22 · 2012: 17
- FWCI
- 24.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 64738, R01HL064738)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- HDL subpopulations, apolipoprotein A-I, HDL particle size, cardiovascular risk prediction, recurrent cardiovascular events, coronary artery disease, myocardial infarction, stroke, HDL cholesterol, triglycerides, veterans
- MeSH terms
- Aged, Cardiovascular Diseases, Coronary Disease, Follow-Up Studies, Humans, Lipoproteins, LDL, Male, Middle Aged, Myocardial Infarction, Predictive Value of Tests, Recurrence, Risk Factors, United States, United States Department of Veterans Affairs, Biomarkers, Proportional Hazards Models, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
